Identification of the Major Protein Adduct Formed in Rat Liver After Thioacetamide Administration1

Total Page:16

File Type:pdf, Size:1020Kb

Identification of the Major Protein Adduct Formed in Rat Liver After Thioacetamide Administration1 [CANCER RESEARCH 41. 3430-3435, September 1981] 0008-5472/81 70041-0000$02.00 Identification of the Major Protein Adduct Formed in Rat Liver after Thioacetamide Administration1 Martin C. Dyroff2 and Robert A. Neal3 Center in Environmental Toxicology, Department of Biochemistry. Vanderbilt University School of Medicine. Nashville, Tennessee 37232 ABSTRACT that metabolism of thioacetamide-S-oxide by rat liver micro- somes results in the formation of a reactive metabolite(s) which The in vivo covalent binding of the hepatocarcinogen thioa- binds to calf thymus DNA, calf liver RNA, polyguanylate, and cetamide to rat liver protein has been examined. Following administration of 3H- or '"C-labeled thioacetamide, the modified polyadenylate (23). In the present investigation, we have de termined the structure of the major amino acid adduct of liver amino acids present in the hepatic cytosolic proteins were proteins formed on administration of [3H]- or [1-'"C]thioaceta- isolated by enzymatic digestion and ion-exchange chromatog- mide to rats. raphy. Approximately 70% of the radioactivity covalently bound to cytosolic protein was recovered in a compound which upon MATERIALS AND METHODS acid hydrolysis yielded lysine and radiolabeled acetate. Addi tional studies indicated the structure of this adduct was N-e- Chemicals. [3H]Thioacetamide (specific activity, 25 mCi/mmol) and acetyllysine. [1-'4C]thioacetamide (specific activity, 1 mCi/mmol) were synthesized from [3H]acetonitrile (3.75 Ci/mmol) and [1-'4C]acetonitrile (10 mCi/ mmol) as described previously (17, 25). The [3H]acetonitrile was the INTRODUCTION product of New England Nuclear, Boston, Mass., and the [1-'"C]ace- Thioacetamide produces centrilobular hepatic necrosis (1, tonitrile was obtained from ICN Chemical Radioisotopes Div., Irvine, 8), bile duct proliferation (4, 6), and liver cirrhosis (4, 7) in rats. Calif. The purity of the radiolabeled thioacetamide was determined by thin-layer chromatography (17) to be greater than 98%. [D3]Thioacet- Thioacetamide is rapidly metabolized in vivo in the rat to sulfate (15), acetamide (20), and thioacetamide-S-oxide (2,16). Acet- amide was synthesized using [D3]acetonitrile (Pfaltz and Bauer, Inc., Stamford, Conn.) as described previously (25). Phénobarbital, 3- amide does not produce hepatotoxic effects such as those methylcholanthrene, pronase, leucine amino peptidase, and amino acid observed with thioacetamide even at very high doses (3). standards were obtained from Sigma Chemical Co., St. Louis, Mo.; W- However, an equimolar dose of thioacetamide-S-oxide pro e-acetyllysine was obtained from Vega-Fox Biochemicals, Tucson, duces a more severe necrosis and at an earlier time after Ariz.; dimethylformamide dimethylacetal and 3% OV-17 on Chromo- administration than does thioacetamide (8, 16). Following ad sorb W(HP) were from Pierce Chemical Co., Rockford, III.; Porapak Q ministration of [3H]- (16, 20) or [1-14C]thioacetamide (16), co was from Alltech Associates, Arlington Heights, III.; Sephacryl S-200 valent binding of radioactivity to cellular macromolecules can was obtained from Pharmacia Fine Chemicals, Inc., Piscataway, N. J.; be detected. After administration of [35S]thioacetamide or Dowex 50W-X8 was from Bio-Rad Laboratories, Richmond, Calif.; and [35S]thioacetamide-S-oxide to rats, only trace amounts of co the 4.6-mm x 25-cm Zorbax octadecyl silane column was the product of DuPont, Wilmington, Del. Omnifluor was obtained from New England valently bound radioactivity (16) can be detected. However, Nuclear, and Nuclear-Chicago solubilizer and ACS were from Amer- Raw and Rockwell (19) have reported a significantly higher sham/Searle Corp., Arlington Heights, III. labeling of the protein in the nucleolus as compared to other Animals. Male Sprague-Dawley rats (HaríanIndustries) (150 to 160 subcellular fractions in rabbits 2 hr after administration of g) were fed a commercial diet of Purina rat chow ad libitum. The [35S]thioacetamide. cytochrome P-450 monooxygenase activity of rat liver was induced by Rees ef al. (20) proposed that the incorporation of radioac i.p. injection of phénobarbital (80 mg/kg) in 1.15% KCI at 72, 48, and tivity from [3H]thioacetamide into macromolecules was the re 24 hr or 3-methylcholanthrene (40 mg/kg) in corn oil 48 hr prior to administration of [3H]thioacetamide (2.67 mmol/kg; 2 ¿iCi/g body sult of conversion of the metabolite acetamide to acetate which weight), [1-14C]thioacetamide (2.67 mmol/kg; 0.33 ¿iCi/g body entered the metabolic pool and became incorporated into weight), or [D3]thioacetamide (2.67 mmol/kg). Following thioacetamide endogenous molecules. However, Porter ef al. (16) have dem administration, the rats were fasted but allowed unlimited access to onstrated that administration of a dose of radiolabeled aceta water until sacrifice 12 hr later. mide, estimated to approximate the levels formed in vivo after Subcellular Fractionation. Rats were stunned by a blow to the head thioacetamide administration, does not result in significant and decapitated. The livers were perfused in situ with ice-cold 1.15% radiolabeling of hepatic macromolecules. KCI prior to excision and immersion in ice-cold 1.15% KCI. A portion Recent results have suggested that the reactive metabolite of each liver was removed for determination of its content of radioac of thioacetamide which becomes covalently bound is a further tivity by combustion in a Packard Tri-Carb tissue oxidizer. Subcellular oxidation product of thioacetamide-S-oxide, perhaps thioacet- fractionation of the remainder of each liver was performed as described amide-S-dioxide (8, 17), formed in a reaction catalyzed by previously (5). Purified nuclei were prepared by the hypertonic sucrose amine oxidase (18, 26), the cytochrome P-450-containing method of Spelsberg ef al. (21). All subcellular fractions obtained by centrifugation were resuspended in the homogenization buffer to a final monooxygenases (8, 16), or both. It has also been reported concentration of 2 g wet weight liver per ml. Aliquots of each subcellular 1This work was supported by Grants ES 00075 and ES 00267. fraction were analyzed for protein by the method of Lowry ef al. (11 ), 2Recipient of Grant ES 07028. using bovine serum albumin as the standard, and for radioactivity, by 3To whom requests for reprints should be addressed. liquid scintillation counting after solubilization with Nuclear-Chicago Received March 20, 1981; accepted June 11,1981. tissue solubilizer and neutralization with glacial acetic acid. 3430 CANCER RESEARCH VOL. 41 Downloaded from cancerres.aacrjournals.org on October 3, 2021. © 1981 American Association for Cancer Research. Hepatic Protein Adduci of Thioacetamide Determination of Covalent Binding. Protein and other macromole- Amino Acid. The radioactive compound recovered from the amino acid cules present in aliquots of the subcellular fractions corresponding to analyzer and purified from buffer components was derivatized using 1 g, wet weight, of liver were precipitated by adding 20 volumes of dimethylformamide dimethylacetal as described by Thenot and Horning cold 95% ethanol. The precipitated material was homogenized in the (22). The derivatized compound was chromatographed on a 2-mm x 6- 20 volumes of ethanol using a Son/all Omnimixer at top speed for 30 ft column of 3% OV-1 7 on Chromosorb W(HP). The Chromatographie sec and then centrifuged for 10 min at 20,000 x g. This cycle was conditions were: flame ionization detector, 275°; injector, 250°; and repeated until the radioactivity in the supernatant was less than 2 times column, 200° for the first 10 min and then temperature programmed background (5). The radioactivity associated with the remaining pre 15°/min to a final temperature of 250°. The carrier gas was helium cipitated material was considered to be covalently bound. This material maintained at a flow rate of 20 ml/min. Alternatively, the 3H-labeled was solubilized by heating for 1 hr at 60°in N NaOH and was assayed adduct was initially esterified with methanol:N HCI at 100° for 15 min. for protein and radioactivity. After removal of the solvent, the resulting mixture was reacted with Aliquots of the cytosolic fraction were chromatographed on a 1.5- x trifluoroacetic anhydride in méthylènechloride at room temperature for 50-cm column of Sephacryl S-200. The column was eluted with 0.05 15 min. The solvent was removed under a stream of nitrogen, and the M sodium phosphate buffer, pH 7.4, and the effluent was monitored for sample was dissolved in methanol and analyzed on a 2-mm x 6-ft UV absorbance at 280 nm and for radioactivity. Aliquots of the hepatic column of 3% OV-17 in the gas Chromatograph. The Chromatographie cytosolic fraction were also analyzed by sodium dodecyl sulfate:poly- conditions were: flame ionization or electron capture detector, 260°; acrylamide gel electrophoresis on 7.5% gels according to the method injector, 210°; and column, 140° initially and then programmed 10°/ of Laemmli ef al. (9). The gels were stained with Coomassie Brilliant min to a final temperature of 250°. The carrier gas was nitrogen and Blue and scanned for absorbance at 595 nm. Subsequently, the gels maintained at a flow rate of 20 ml/min. Radioactivity was monitored by were sliced in 2-mm pieces, the slices were solubilized using 30% bubbling the column effluent through 18 ml of ACS scintillation cocktail H2C>2and 70% HCICX,according to the method of Mahin and Lofberg for timed intervals and counting the timed fractions. (12), and analyzed for radioactivity. A Finnigan Model 3200 GC-MS, operated in the electron impact Enzymatic Hydrolysis of Hepatic Cytosolic Protein. Cytosolic frac mode, was used to obtain the mass spectrum of the thioacetamide- tions from the livers of rats administered [3H> or [1-14C]thioacetamide modified amino acid which was derivatized using the procedure de were dialyzed for 24 hr at 4°against 0.05 M phosphate buffer, pH 7.4, scribed by Thenot and Horning (22).
Recommended publications
  • Report of the Advisory Group to Recommend Priorities for the IARC Monographs During 2020–2024
    IARC Monographs on the Identification of Carcinogenic Hazards to Humans Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 CONTENTS Introduction ................................................................................................................................... 1 Acetaldehyde (CAS No. 75-07-0) ................................................................................................. 3 Acrolein (CAS No. 107-02-8) ....................................................................................................... 4 Acrylamide (CAS No. 79-06-1) .................................................................................................... 5 Acrylonitrile (CAS No. 107-13-1) ................................................................................................ 6 Aflatoxins (CAS No. 1402-68-2) .................................................................................................. 8 Air pollutants and underlying mechanisms for breast cancer ....................................................... 9 Airborne gram-negative bacterial endotoxins ............................................................................. 10 Alachlor (chloroacetanilide herbicide) (CAS No. 15972-60-8) .................................................. 10 Aluminium (CAS No. 7429-90-5) .............................................................................................. 11
    [Show full text]
  • ECLSS Assessments Sept-2015 Baseline
    JSC-66869 Baseline Guidelines for the Assessment of Chemicals and Materials for Impacts to Environmental Control and Life Support Systems and Habitable Volumes of Crewed Spacecraft Environmental Control and Life Support Systems Crew and Thermal Systems Division Engineering Directorate September 2015 Baseline Cleared for Internal NASA Release National Aeronautics and Space Administration Lyndon B. Johnson Space Center Houston, Texas JSC 66869 Baseline Guidelines for the Assessment of Chemicals and Materials for Impacts to Environmental Control and Life Support Systems and Habitable Volumes of Crewed Spacecraft Prepared by: Concurred by: ii JSC 66869 Baseline CONTENTS 1.0 INTRODUCTION ................................................................................................................................................. 1 1.1 PURPOSE OF ECLSS IMPACT ASSESSMENTS ......................................................................................................... 1 1.2 COMPILATION AND DISTRIBUTION OF ECLSS IMPACT ASSESSMENTS.................................................................. 2 2.0 ECLSS AND CABIN ENVIRONMENT IMPACT RATING DEFINITIONS ................................................ 2 3.0 IDENTIFYING CHEMICALS IN PAYLOAD/HARDWARE.......................................................................... 3 4.0 GENERAL GUIDELINES BY WHICH ECLSS HARDWARE IMPACTS AND CABIN ENVRIONMENT IMPACTS ARE ASSESSED. ...................................................................................................... 4 4.1 REQUIREMENTS
    [Show full text]
  • List of Lists
    United States Office of Solid Waste EPA 550-B-10-001 Environmental Protection and Emergency Response May 2010 Agency www.epa.gov/emergencies LIST OF LISTS Consolidated List of Chemicals Subject to the Emergency Planning and Community Right- To-Know Act (EPCRA), Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) and Section 112(r) of the Clean Air Act • EPCRA Section 302 Extremely Hazardous Substances • CERCLA Hazardous Substances • EPCRA Section 313 Toxic Chemicals • CAA 112(r) Regulated Chemicals For Accidental Release Prevention Office of Emergency Management This page intentionally left blank. TABLE OF CONTENTS Page Introduction................................................................................................................................................ i List of Lists – Conslidated List of Chemicals (by CAS #) Subject to the Emergency Planning and Community Right-to-Know Act (EPCRA), Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) and Section 112(r) of the Clean Air Act ................................................. 1 Appendix A: Alphabetical Listing of Consolidated List ..................................................................... A-1 Appendix B: Radionuclides Listed Under CERCLA .......................................................................... B-1 Appendix C: RCRA Waste Streams and Unlisted Hazardous Wastes................................................ C-1 This page intentionally left blank. LIST OF LISTS Consolidated List of Chemicals
    [Show full text]
  • United States Patent Office Patented Apr
    3,726,878 United States Patent Office Patented Apr. 10, 1973 2 The novel pyridine thioacetamide derivatives of the 3,726,878 present invention are represented by the following general PYRONE THOACETAMIDE DERVATIVES formula: Yoshio Kanai, Osaka, Haruomi Honda, Kawanishi, Hyogo, Yasushi Sanno, Osaka, Kawani, Akira Nohara, Kyoto, and Morio Kanno, Osaka, Japan, assignors to Takeda Chemical Industries, Ltd., Osaka, Japan (Ri)n R. No Drawing. Filed July 7, 1970, Ser. No. 53,008 s'-OH,C-C-N N Claims priority, application Japan, July 8, 1969, R 44/53,946 Int, C. C0731/50 O wherein R1 is H, lower alkyl, alkoxy or halogen and n is U.S. C. 260-294.8 E 19 Claims an integer of 1 to 4, or wherein (R) is a divalent straight chain hydrocarbon radical having 4 carbon atoms which is attached to the 5- and 6-positions of the pyridine ABSTRACT OF THE DISCLOSURE ring, each of R2 and R3 independently is hydrogen, lower Compounds of the formula 5 alkyl, aralkyl, aryl, or where R and R3 form a hetero cyclic ring together with the adjacent nitrogen atom, with a proviso that at least one of R, R2 and Ra is other than hydrogen. S R The lower alkyl represented by R1, Ra and Rs may be 20 the same or different and is preferably one having up to 4 carbon atoms such as methyl, ethyl, propyl, isopropyl, J-CH-C-NC Ra butyl, iso-butyl, sec-butyl and tert-butyl. The alkoxy represented by R1 is preferably lower alkoxy having up to 4 carbon atoms such as methoxy, ethoxy, propoxy, wherein R1 is hydrogen, lower alkyl, lower alkoxy or 25 iso-propoxy, butoxy, iso-butoxy, sec-butoxy and tert halogen and n is an integer of 1 to 4, or wherein (R) butoxy.
    [Show full text]
  • Thioacetamide
    Common Name: THIOACETAMIDE CAS Number: 62-55-5 RTK Substance number: 1844 DOT Number: None Date: January 1996 Revision: March 2002 ------------------------------------------------------------------------- ------------------------------------------------------------------------- HAZARD SUMMARY WORKPLACE EXPOSURE LIMITS * Thioacetamide can affect you when breathed in and by No occupational exposure limits have been established for passing through your skin. Thioacetamide. This does not mean that this substance is not * Thioacetamide should be handled as a CARCINOGEN-- harmful. Safe work practices should always be followed. WITH EXTREME CAUTION. * Thioacetamide can irritate the eyes on contact. * Thioacetamide may be a CARCINOGEN in humans. * Exposure to Thioacetamide can irritate the nose, throat There may be no safe level of exposure to a carcinogen, so and lungs causing coughing. all contact should be reduced to the lowest possible level. * High or repeated exposure can cause liver damage severe * It should be recognized that Thioacetamide can be enough to cause death. absorbed through your skin, thereby increasing your exposure. IDENTIFICATION Thioacetamide occurs as a colorless leaf-like material with a WAYS OF REDUCING EXPOSURE slight Sulfur-like odor. It is used as a substitute for Hydrogen * Where possible, enclose operations and use local exhaust Sulfide in the laboratory and as a stabilizer of motor fuel. ventilation at the site of chemical release. If local exhaust ventilation or enclosure is not used, respirators should be REASON FOR CITATION worn. * Thioacetamide is on the Hazardous Substance List * Wear protective work clothing. because it is cited by NTP, DEP, IARC and EPA. * Wash thoroughly immediately after exposure to * This chemical is on the Special Health Hazard Substance Thioacetamide and at the end of the workshift.
    [Show full text]
  • Methionine | C5H11NO2S - Pubchem
    24/9/2020 Methionine | C5H11NO2S - PubChem COMPOUND SUMMARY Methionine PubChem CID: 6137 Structure: 2D 3D Crystal Find Similar Structures Chemical Safety: Laboratory Chemical Safety Summary (LCSS) Datasheet Molecular Formula: C5H11NO2S L-methionine 63-68-3 methionine Synonyms: h-Met-oh (S)-2-Amino-4-(methylthio)butanoic acid More... Molecular Weight: 149.21 g/mol Modify: Create: Dates: 2020-09-19 2004-09-16 Methionine is one of nine essential amino acids in humans (provided by food), Methionine is required for growth and tissue repair. A sulphur-containing amino acid, methionine improves the tone and pliability of skin, hair, and strengthens nails. Involved in many detoxifying processes, sulphur provided by methionine protects cells from pollutants, slows cell aging, and is essential for absorption and bio-availability of selenium and zinc. Methionine chelates heavy metals, such as lead and mercury, aiding their excretion. It also acts as a lipotropic agent and prevents excess fat buildup in the liver. (NCI04) NCI Thesaurus (NCIt) L-Methionine, also known as liquimeth or pedameth, belongs to the class of organic compounds known as methionine and derivatives. Methionine and derivatives are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. L-Methionine is a drug which is used for protein synthesis including the formation of same, l-homocysteine, l-cysteine, taurine, and sulfate. L-Methionine exists as a solid, soluble (in water), and a moderately acidic compound (based on its pKa). L-Methionine has been found throughout most human tissues, and has also been detected in most biofluids, including feces, cerebrospinal fluid, saliva, and blood.
    [Show full text]
  • Thioacetamide MSDS
    He a lt h 2 1 Fire 1 2 0 Re a c t iv it y 0 Pe rs o n a l Pro t e c t io n E Material Safety Data Sheet Thioacetamide MSDS Section 1: Chemical Product and Company Identification Product Name: Thioacetamide Contact Information: Catalog Codes: SLT1831, SLT3124 Sciencelab.com, Inc. 14025 Smith Rd. CAS#: 62-55-5 Houston, Texas 77396 RTECS: AC8925000 US Sales: 1-800-901-7247 International Sales: 1-281-441-4400 TSCA: TSCA 8(b) inventory: Thioacetamide Order Online: ScienceLab.com CI#: Not available. CHEMTREC (24HR Emergency Telephone), call: Synonym: Ethanethioamide; Acetothioamide; 1-800-424-9300 Thiacetamide; Thioacetimidic acid International CHEMTREC, call: 1-703-527-3887 Chemical Name: Acetamide, thio- For non-emergency assistance, call: 1-281-441-4400 Chemical Formula: C2-H5-N-S Section 2: Composition and Information on Ingredients Composition: Name CAS # % by Weight Thioacetamide 62-55-5 100 Toxicological Data on Ingredients: Thioacetamide: ORAL (LD50): Acute: 301 mg/kg [Rat]. Section 3: Hazards Identification Potential Acute Health Effects: Hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation. Slightly hazardous in case of skin contact (permeator). Potential Chronic Health Effects: CARCINOGENIC EFFECTS: Classified 2B (Possible for human.) by IARC. Classified 2 (Some evidence.) by NTP. MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. Mutagenic for bacteria and/or yeast. TERATOGENIC EFFECTS: Not available. DEVELOPMENTAL TOXICITY: Not available. The substance may be toxic to liver. Repeated or prolonged exposure to the substance can produce target organs damage. Section 4: First Aid Measures Eye Contact: p.
    [Show full text]
  • Evaluation of Thioamides, Thiolactams and Thioureas As Hydrogen Sulfide
    Bioorganic Chemistry 88 (2019) 102941 Contents lists available at ScienceDirect Bioorganic Chemistry journal homepage: www.elsevier.com/locate/bioorg Evaluation of thioamides, thiolactams and thioureas as hydrogen sulfide T (H2S) donors for lowering blood pressure Ewelina Zaorskaa, Tomasz Hutscha, Marta Gawryś-Kopczyńskaa, Ryszard Ostaszewskib, ⁎ ⁎ Marcin Ufnala, , Dominik Koszelewskib, a Department of Experimental Physiology and Pathophysiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Pawińskiego 3c, 02-106 Warsaw, Poland b Institute of Organic Chemistry, Polish Academy of Sciences Kasprzaka 44/52, 01-224 Warsaw, Poland ARTICLE INFO ABSTRACT Keywords: Hydrogen sulfide 2(H S) is a biologically important gaseous molecule that exhibits promising protective effects Hydrogen sulfide against a variety of pathological processes. For example, it was recognized as a blood pressure lowering agent. Thioamides Aligned with the need for easily modifiable platforms for the2 H S supply, we report here the preparation and the Thiolactams H2S release kinetics from a series of structurally diversified thioamides, thiolactams and thioureas. Three dif- Thiourea ferent thionation methods based on the usage of a phosphorus pentasulfide and Lawesson reagent were applied Cardiovascular to prepare the target thioamides and thiolactams. Furthermore, obtained H2S donors were evaluated both in in vivo and in vitro studies. The kinetic parameters of the liberating H2S was determined and compared with NaHS and GYY4137 using two different detection technics i.e.; fluorescence labeling 7-azido-4-methyl-2H-chromen-2- one and 5,5‘-dithiobis (2-nitrobenzoic acid), sulfhydryl probe, also known as the Ellman’s reagent. We have proved that the amount of releasing H2S from these compounds is controllable through structural modifications.
    [Show full text]
  • Improved Process for the Preparation of Thioacetamide
    Europaisches Patentamt (19) European Patent Office Office europeenpeen des brevets EP 0 648 742 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Intel e C07C 327/42 of the grant of the patent: 22.01.1997 Bulletin 1997/04 (21) Application number: 93870201.6 (22) Date of filing: 14.10.1993 (54) Improved process for the preparation of thioacetamide Verbessertes Verfahren zur Herstellung von Thioacetamid Procede perfectionne pour la preparation du thioacetamide (84) Designated Contracting States: (74) Representative: Tanner, James Percival et al AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL ROHM AND HAAS (UK) LTD. PT SE European Operations Patent Department Lennig House (43) Date of publication of application: 2 Mason's Avenue 19.04.1995 Bulletin 1995/16 Croydon CR9 3NB (GB) (73) Proprietor: ROHM AND HAAS COMPANY (56) References cited: Philadelphia, Pennsylvania 19106-2399 (US) CA-A- 946 392 US-A- 3 979 452 (72) Inventor: Williams, Eric Lee St. Ann, Missouri 63074 (US) DO CM ^> Is- 00 ^- CO Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice the Patent Office of the Notice of shall be filed in o to European opposition to European patent granted. opposition a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. a. 99(1) European Patent Convention). LU Printed by Jouve, 75001 PARIS (FR) 1 EP 0 648 742 B1 2 Description thioacetamide for subsequent reaction(s) such as that shown below.
    [Show full text]
  • Thioacetamide
    Thioacetamide sc-213031 Material Safety Data Sheet Hazard Alert Code EXTREME HIGH MODERATE LOW Key: Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION PRODUCT NAME Thioacetamide STATEMENT OF HAZARDOUS NATURE CONSIDERED A HAZARDOUS SUBSTANCE ACCORDING TO OSHA 29 CFR 1910.1200. NFPA FLAMMABILITY1 HEALTH2 HAZARD INSTABILITY0 SUPPLIER Santa Cruz Biotechnology, Inc. 2145 Delaware Avenue Santa Cruz, California 95060 800.457.3801 or 831.457.3800 EMERGENCY ChemWatch Within the US & Canada: 877-715-9305 Outside the US & Canada: +800 2436 2255 (1-800-CHEMCALL) or call +613 9573 3112 SYNONYMS C2-H5-S-N, CH3CSNH2, acetothioamide, ethanethioamide, TAA, thiacetamide Section 2 - HAZARDS IDENTIFICATION CHEMWATCH HAZARD RATINGS Min Max Flammability: 1 Toxicity: 2 Body Contact: 2 Min/Nil=0 Low=1 Reactivity: 1 Moderate=2 High=3 Chronic: 3 Extreme=4 CANADIAN WHMIS SYMBOLS 1 of 8 EMERGENCY OVERVIEW RISK Harmful if swallowed. May cause CANCER. Irritating to eyes and skin. Harmful to aquatic organisms, may cause long-term adverse effects in the aquatic environment. * (limited evidence). POTENTIAL HEALTH EFFECTS ACUTE HEALTH EFFECTS SWALLOWED ! Accidental ingestion of the material may be harmful; animal experiments indicate that ingestion of less than 150 gram may be fatal or may produce serious damage to the health of the individual. EYE ! This material can cause eye irritation and damage in some persons. SKIN ! This material can cause inflammation of the skin oncontact in some persons. ! The material may accentuate any pre-existing dermatitis condition. ! Open cuts, abraded or irritated skin should not be exposed to this material. ! Entry into the blood-stream, through, for example, cuts, abrasions or lesions, may produce systemic injury with harmful effects.
    [Show full text]
  • Hybrid Computational Toxicology Models for Regulatory Risk Assessment Prachi Pradeep Marquette University
    Marquette University e-Publications@Marquette Dissertations (2009 -) Dissertations, Theses, and Professional Projects Hybrid Computational Toxicology Models for Regulatory Risk Assessment Prachi Pradeep Marquette University Recommended Citation Pradeep, Prachi, "Hybrid Computational Toxicology Models for Regulatory Risk Assessment" (2015). Dissertations (2009 -). Paper 503. http://epublications.marquette.edu/dissertations_mu/503 HYBRID COMPUTATIONAL TOXICOLOGY MODELS FOR REGULATORY RISK ASSESSMENT by PRACHI PRADEEP A Dissertation submitted to the Faculty of the Graduate School, Marquette University, in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Milwaukee, Wisconsin May 2015 ABSTRACT HYBRID COMPUTATIONAL TOXICOLOGY MODELS FOR REGULATORY RISK ASSESSMENT Prachi Pradeep Marquette University, 2015 Computational toxicology is the development of quantitative structure activity relationship (QSAR) models that relate a quantitative measure of chemical structure to a biological effect. In silico QSAR tools are widely accepted as a faster alternative to time-consuming clinical and animal testing methods for regulatory risk assessment of xenobiotics used in consumer products. However, different QSAR tools often make contrasting predictions for a new xenobiotic and may also vary in their predictive ability for different class of xenobiotics. This makes their use challenging, especially in regulatory applications, where transparency and interpretation of predictions play a crucial role in the development of safety
    [Show full text]
  • Copper Complexation by Thiol Compounds in Estuarine Waters
    Marine Chemistry 82 (2003) 71–89 www.elsevier.com/locate/marchem Copper complexation by thiol compounds in estuarine waters Luis M. Laglera, Constant M.G. van den Berg* Oceanography Laboratories, University of Liverpool, Liverpool L69 7ZL, UK Received 14 May 2002; received in revised form 10 February 2003; accepted 21 March 2003 Abstract The stability of copper complexes with thiol substances in estuarine waters was determined for the first time using a new procedure based on cathodic stripping voltammetry (CSV). The free thiol concentration was monitored during titrations with copper in the presence of a competing ligand salicylaldoxime (SA); concentrations of copper-complexing ligands and conditional stability constants were determined simultaneously but independently. The decrease in the free thiol concentration with increasing copper concentration was used as an independent measure of the thiol-complex stability. The conditional stability constant of the thiol complexes (log KCuThiolV ) was between 12.3 and 14.1, and decreased with increasing salinity. The copper complexing titrations were found to fit to two complexing ligands: L1 with concentrations between 10 and 33 nM, and L2 between 14 and 300 nM. The complex stability of most of the thiols was similar to that of CuL2. Titrations at different detection windows showed a shift in the thiol complex stability suggesting that a second thiol species was present. It is therefore possible that L1 is also a thiol species. The estimated thiol concentrations can account for up to half of the total ligand concentration at low to intermediate salinities and for all of the ligands at high salinities. D 2003 Elsevier Science B.V.
    [Show full text]